Download pdf
EMA qualification opinion on Cellular therapy module of the EBMT Registry
EBMT requested qualification of the cellular therapy module of the EBMT Registry as suitable for performing pharmacoepidemiological studies for regulatory purposes, concerning CAR-T cell therapy for haematological malignancies.